Terminology Service for NFDI4Health
gp100:280-288 Peptide Vaccine
Go to external page
http://purl.obolibrary.org/obo/NCIT_C2767
A vaccine consisting of the amino acids 280 through 288 of the melanoma antigen glycoprotein 100 (gp100) with potential antineoplastic activity. Vaccination with gp100:280-288 peptide may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the gp100 antigen, resulting in decreased tumor growth. (NCI04) [ ]
Term info
Label
gp100:280-288 Peptide Vaccine
Synonyms
- gP100 Peptide Melanoma Vaccine YLEPGPVTA
- gp100:280-288 Peptide
- gp100:280-288 Peptide Vaccine
Subsets
NCIT_C128784
Has Target
http://purl.obolibrary.org/obo/NCIT_C2386
Legacy Concept Name
gp100_280-288_Peptide
NSC Code
676539
Preferred Name
gp100:280-288 Peptide Vaccine
Semantic Type
Pharmacologic Substance, Amino Acid, Peptide, or Protein
UMLS CUI
C1515632
code
C2767
Term relations
Subclass of:
- Peptide Vaccine
- Chemical_Or_Drug_Has_Physiologic_Effect some T-Cell Activation
- Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some Cytotoxic T-Lymphocyte
- Chemical_Or_Drug_Has_Mechanism_Of_Action some Antigen Sensitization
- Chemical_Or_Drug_Affects_Abnormal_Cell some Melanoma Cell
- Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation